Sonnet BioTherapeutics SONN
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q1 | 1.34 | 121.14 | -0.69 | -4,229 | -3 | |
| 2024Q4 | 1.46 | 94.90 | -1.56 | -2,849 | -3 | |
| 2024Q3 | 6.69 | 101.44 | -6.15 | -3,173 | -3 | |
| 2024Q2 | 7.50 | 100.66 | -6.15 | -3,529 | -4 | |
| 2024Q1 | 14.88 | -1060.00 | 0.93 | -3,869 | 0 | |
| 2023Q4 | 13.92 | 109.41 | -2.46 | -1,279 | -1 | |
| 2023Q3 | 22.92 | 97.91 | 6.71 | -3,600 | -4 | |
| 2023Q2 | 86.24 | 99.21 | 17.28 | -3,915 | -4 | |
| 2023Q1 | 63.36 | 99.96 | -28.16 | -5,665 | -6 | |
| 2022Q4 | 202.40 | 101.26 | -140.96 | -5,612 | -6 | |
| 2022Q3 | 258.72 | 99.22 | -294.15 | -7,377 | -7 | |
| 2022Q2 | 689.91 | 99.87 | -320.35 | -7,867 | -8 | |
| 2022Q1 | 926.45 | 100.02 | -336.19 | -8,210 | -8 | |
| 2021Q4 | 1017.86 | 100.23 | -253.47 | -6,215 | -6 | |
| 2021Q3 | 1493.16 | 99.93 | -216.58 | -6,947 | -7 | |
| 2021Q2 | 3893.06 | 102.03 | -665.27 | -6,240 | -6 | |
| 2021Q1 | 5543.91 | 99.97 | -788.47 | -6,037 | -6 | |
| 2020Q4 | 5494.63 | 99.78 | -837.75 | -5,864 | -6 | |
| 2020Q3 | 6332.38 | 99.48 | -11654.53 | -7,491 | -8 | |
| 2020Q2 | 8968.82 | 99.80 | -3326.35 | -11,766 | -12 |